Oxford BioMedica PLC buy melinda
Start price
22.09.10
/
50%
€3.00
Target price
22.03.11
€4.50
Performance (%)
-41.67%
End price
22.03.11
€1.75
Summary
This prediction ended on 22.03.11 with a price of €1.75. Massive losses of -41.67% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Oxford BioMedica PLC | 7.035% | 7.035% | -16.471% | -72.516% |
iShares Core DAX® | -1.377% | -1.442% | 10.458% | 14.043% |
iShares Nasdaq 100 | 0.827% | -5.117% | 22.834% | 40.300% |
iShares Nikkei 225® | 0.198% | -0.851% | 7.804% | 7.932% |
iShares S&P 500 | 1.364% | -0.887% | 22.672% | 41.522% |
Comments by melinda for this prediction
In the thread Oxford BioMedica PLC diskutieren
Biopharma-
Oxford BioMedica ist ein biopharmazeutisches Unternehmen in der Entwicklung und Kommerzialisierung von innovativen Gen-basierter Medikamente spezialisiert
(Laufzeit überschritten)